Estarylla and Sinusitis - a phase IV clinical study of FDA data

Summary:

Sinusitis is reported as a side effect among people who take Estarylla (ethinyl estradiol; norgestimate), especially for people who are female, 30-39 old, also take Proair Hfa, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Sinusitis when taking Estarylla. It is created by eHealthMe based on reports of 550 people who have side effects when taking Estarylla from the FDA, and is updated regularly.

What is Estarylla?

Estarylla has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 594 Estarylla users. Check the latest studies of Estarylla.

What is Sinusitis?

Sinusitis (inflammation of sinus) is found to be associated with 2,401 drugs and 2,724 conditions by eHealthMe. Check the latest studies of Sinusitis.

On Jul, 20, 2026

550 people reported to have side effects when taking Estarylla.
Among them, 13 people (2.36%) have Sinusitis.

Among these 13 people:

What is the gender of people who have Sinusitis when taking Estarylla? *

female: 100 %
male: 0.0 %

What is the age of people who have Sinusitis when taking Estarylla? *

What are other drugs people take besides Estarylla? *

What are other side effects people have besides Sinusitis? *

Vitamin B12 Decreased: 6 people, 46.15%
Nausea (feeling of having an urge to vomit): 6 people, 46.15%
Blood Iron Decreased: 6 people, 46.15%
Blood Potassium Decreased: 6 people, 46.15%
Brain Neoplasm (tumour of brain): 6 people, 46.15%
Infusion Site Pain: 6 people, 46.15%
Injection Site Pruritus (severe itching at injection site): 6 people, 46.15%
Joint Injury: 6 people, 46.15%
The Flu (the flu is caused by an influenza virus): 6 people, 46.15%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 46.15%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 7 people, 53.85%
Primary Immunodeficiency Syndrome: 6 people, 46.15%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 30.77%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.69%
Hidradenitis (chronic disease of a type of sweat gland): 1 person, 7.69%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 7.69%
Asthma: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Estarylla and have Sinusitis?

- Check whether Sinusitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Estarylla:

Estarylla (594 reports)

Sinusitis treatments and more:

Sinusitis (153,485 reports)

How severe was Sinusitis and when was it recovered:

Sinusitis in Estarylla

Expand to all the drugs that have ingredients of ethinyl estradiol; norgestimate:

Sinusitis and drugs with ingredients of ethinyl estradiol; norgestimate (208 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Estarylla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis:

Sinusitis (2,401 drugs)

Browse all the conditions that are associated with Sinusitis:

Sinusitis (2,724 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norgestimate (the active ingredients of Estarylla) and Estarylla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.